Status:
COMPLETED
Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Colon Cancer
Rectal Cancer
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient ...
Detailed Description
PRIMARY OBJECTIVES: I. To test a patient activation intervention to improve colorectal cancer (CRC) screening rates using fecal occult blood test (FOBT) among male and female patients 50 years and ol...
Eligibility Criteria
Inclusion
- Patient is 50+ years of age
- Patient is in need of CRC screening
- Patient is in good health (e.g. no contraindications to having CRC screening, such as a history of colorectal cancer, congenital heart failure, renal failure, dialysis, dementia, severe arthritis, etc.)
- Patient is not pregnant
- Patient is able to speak, read, and understand English
Exclusion
- Patient is within CRC screening guidelines
- Patient is at high risk for CRC
- Patient cannot understand English
- Patient cannot complete a CRC screening test
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
284 Patients enrolled
Trial Details
Trial ID
NCT01801059
Start Date
September 1 2007
End Date
December 1 2010
Last Update
October 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States, 43210